Cargando…
The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer
PURPOSE: The fragile-site associated tumor suppressor (FATS) is a newly identified tumor suppressor involved in radiation-induced tumorigenesis. The purpose of this study was to characterize FATS expression in breast cancers about radiotherapy benefit, patient characteristics, and prognosis. RESULTS...
Autores principales: | Zhang, Jun, Wu, Nan, Zhang, Tiemei, Sun, Tao, Su, Yi, Zhao, Jing, Mu, Kun, Jin, Zhao, Gao, Ming, Liu, Juntian, Gu, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503548/ https://www.ncbi.nlm.nih.gov/pubmed/28402275 http://dx.doi.org/10.18632/oncotarget.16630 |
Ejemplares similares
-
Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer
por: Wu, Nan, et al.
Publicado: (2018) -
Drug resistance gene expression and chemotherapy sensitivity detection in Chinese women with different molecular subtypes of breast cancer
por: Zhao, Jing, et al.
Publicado: (2020) -
Diagnostic and Prognostic Value of DACH1 Methylation in the Sensitivity of Esophageal Cancer to Radiotherapy
por: Huang, Jing, et al.
Publicado: (2022) -
Predictive significance of lymphocyte level and neutrophil‐to‐lymphocyte ratio values during radiotherapy in cervical cancer treatment
por: Zhao, Mengli, et al.
Publicado: (2023) -
The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer
por: Hu, Zhi, et al.
Publicado: (2010)